Status:
TERMINATED
Pilot Study Adapting EAT-PTSD for Anxious Youth
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
Columbia University
Conditions:
Anxiety Disorder of Childhood or Adolescence
Eligibility:
All Genders
13-17 years
Phase:
NA
Brief Summary
The purpose of this research protocol is to adapt the Equine Assisted Therapy (EAT) protocol, which the investigators had developed to help treat PTSD (EAT-PTSD; the Man O' War (MOW) protocol), for us...
Detailed Description
In this pilot study the investigators will explore the use/adaptation of the EAT-PTSD protocol that the investigators developed to treat veterans with Posttraumatic Stress Disorder so that it might be...
Eligibility Criteria
Inclusion
- Youth ages 13-17
- Youth lives with parent
- English speaking (youth and parent) who reside in Westchester, Putnam, Rockland, Bronx, or Manhattan Counties (in New York) OR in Connecticut
- Youth does not have a current substance use problem
- Youth is available for an "after school" group at time the EAT sessions are scheduled
- Parent understands that participation does not affect place on clinic waiting list
- Parent will be able to provide/assure transportation to equestrian center, etc.
- Current diagnosis of Social Anxiety Disorder, Separation Anxiety Disorder, Generalized Anxiety Disorder, or Unspecified Anxiety Disorder
- Parent understands the protocol, agrees to their responsibilities (providing transport, scheduling sessions), and is able to give consent
- Youth understands the protocol and consents (if age 18) or assents (if younger than age 18) of their own free will
Exclusion
- Elevated depression, PTSD, or OCD symptoms of clinical concern
- Elevated risk for suicide/suicidal behavior based on history and current mental state
- Extreme fear of horses
- Orthopedic or other physical limitation that would prevent youth from walking unassessed and/or walking freely in ring
- Acute, unstable, or severe medical disorder (that might prohibit completing the 8 session protocol)
Key Trial Info
Start Date :
April 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 23 2022
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT05298397
Start Date
April 29 2022
End Date
November 23 2022
Last Update
July 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
1051 Riverside Drive
New York, New York, United States, 10032
2
New York State Psychiatric Institute
New York, New York, United States, 10032